API manufacturing unit planned by Symbiotec Lifesciences
Pharma firm Symbiotec Lifesciences has planned an active pharmaceutical ingredient (API) manufacturing unit at Narwar in Ujjain. Spread over 31.09 acres of the land parcel the unit would have a capacity of 1,260 tpa.
The project is expected to commence by September 2022, and the firm is awaiting environment clearance for the project.
Also Read: API Unit Planned By Glenmark Life Sciences